TRVI compared with MBX: revenue, margins and what each company keeps, and the suppliers and customers both name

TRVITrevi Therapeutics, Inc.

Mkt capRevenueRevenue

MBXMBX Biosciences, Inc.

Mkt capRevenueRevenue

Compare

TRVITrevi Therapeutics, Inc.

MBXMBX Biosciences, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

TRVI, solidMBX, dashed

Supply-chain overlap

Revenue flow

TRVI: latest quarter not drawable. MBX: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only TRVI 2

—Keenova Therapeuticsunlistedsupplier

—Par Healthunlistedsupplier

Shared 0

No shared counterparties.

Only MBX 3

—Dr. Richard DiMarchiunlistedsupplier

—Indiana University Research and Technology Corporation ("IURTC")unlistedsupplier

—Trustees of Indiana Universityunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

TRVITrevi Therapeutics, Inc.

13.54▼−1.96%· post 13.54

Mkt cap$1.9B

MBXMBX Biosciences, Inc.

55.82▲+2.35%· post 55.27

ClosedOct 30 '26

Mkt cap$2.7B

Compare

ClosedOct 30 '26

TRVITrevi Therapeutics, Inc.

MBXMBX Biosciences, Inc.

13.54▼−1.96%post 13.54

Price

55.82▲+2.35%post 55.27

$1.9B

Mkt cap

$2.7B

TRVI13.54▼−1.96%vsMBX55.82▲+2.35%ClosedOct 30 '26